- Home
- GDTC vs IHT Comparison
GDTC vs IHT Comparison
Compare GDTC & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- IHT
- Stock Information
- Founded
- GDTC 2018
- IHT 1971
- Country
- GDTC Singapore
- IHT United States
- Employees
- GDTC N/A
- IHT N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- IHT Investment Bankers/Brokers/Service
- Sector
- GDTC Health Care
- IHT Finance
- Exchange
- GDTC Nasdaq
- IHT Nasdaq
- Market Cap
- GDTC 21.5M
- IHT 18.2M
- IPO Year
- GDTC 2023
- IHT N/A
- Fundamental
- Price
- GDTC $2.03
- IHT $2.65
- Analyst Decision
- GDTC Buy
- IHT
- Analyst Count
- GDTC 1
- IHT 0
- Target Price
- GDTC $5.00
- IHT N/A
- AVG Volume (30 Days)
- GDTC 13.2K
- IHT 1.5M
- Earning Date
- GDTC 01-01-0001
- IHT 09-12-2025
- Dividend Yield
- GDTC N/A
- IHT 0.59%
- EPS Growth
- GDTC N/A
- IHT N/A
- EPS
- GDTC N/A
- IHT N/A
- Revenue
- GDTC $368,838.00
- IHT $7,463,789.00
- Revenue This Year
- GDTC $5.37
- IHT N/A
- Revenue Next Year
- GDTC N/A
- IHT N/A
- P/E Ratio
- GDTC N/A
- IHT N/A
- Revenue Growth
- GDTC N/A
- IHT N/A
- 52 Week Low
- GDTC $1.20
- IHT $1.70
- 52 Week High
- GDTC $4.05
- IHT $4.24
- Technical
- Relative Strength Index (RSI)
- GDTC 51.85
- IHT 60.23
- Support Level
- GDTC N/A
- IHT $1.74
- Resistance Level
- GDTC $2.27
- IHT $4.24
- Average True Range (ATR)
- GDTC 0.10
- IHT 0.24
- MACD
- GDTC -0.06
- IHT 0.11
- Stochastic Oscillator
- GDTC 87.67
- IHT 32.80
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.